Jérôme Barrière

Prognostic factors in 1038 women with metastatic breast cancer

R. Largillier, Jean-­Marc Ferrero, J. Doyen et al. · Annals of Oncology · 2008 · 380 citations · Full text

Medicine, Biostatistics, Oncology +14

Afatinib alone or afatinib plus vinorelbine versus investigator's choice of treatment for HER2-positive breast cancer with progressive brain metastases after trastuzumab, lapatinib, or both (LUX-Breast 3): a randomised, open-label, multicentre, phase 2 trial

Javier Cortés, Véronique Dièras, Jungsil Ro et al. · The Lancet Oncology · 2015 · 129 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial

Jean‐Emmanuel Kurtz, Éric Pujade-Lauraine, Ana Oaknin et al. · Journal of Clinical Oncology · 2023 · 103 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Humoral and cellular responses after a third dose of SARS-CoV-2 BNT162b2 vaccine in patients with lymphoid malignancies

Daniel Ré, Barbara Seitz‐Polski, Vesna Brglez et al. · Nature Communications · 2022 · 98 citations · Full text

Medicine, Immunology, Oncology +17

Acceptance of SARS-CoV-2 vaccination among French patients with cancer: a cross-sectional survey

Jérôme Barrière, Jocelyn Gal, Benjamin Hoch et al. · Annals of Oncology · 2021 · 94 citations · Full text

Medicine, Immunology, Oncology +12